Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Heeney

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2008
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenicMax Corbett, Willy M Bogers, Jonathan L Heeney, et al.
Microbiology Spectrum|August 1, 2022
Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in NigeriaAnise N Happi, Testimony J Olumade, Olusola A Ogunsanya, et al.
Virology|October 25, 2008
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challengeWilly M J M Bogers, David Davis, Ilona Baak, et al.
The Journal of Infectious Diseases|September 20, 2014
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsionWilly M Bogers, Herman Oostermeijer, Petra Mooij, et al.
Iscience|October 20, 2023
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunityHazel Stewart, Yongxu Lu, Sarah O'Keefe, et al.
Frontiers in Immunology|August 8, 2022
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 StudyBeatriz Perdiguero, Benedikt Asbach, Carmen E Gómez, et al.
Journal of Virology|June 14, 2003
Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii)Mario L Santiago, Magdalena Lukasik, Shadrack Kamenya, et al.
Journal of Virology|February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Frontiers in Immunology|December 6, 2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 CasesJavier Castillo-Olivares, David A Wells, Matteo Ferrari, et al.
Frontiers in Immunology|March 13, 2023
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variantsGeorge W Carnell, Martina Billmeier, Sneha Vishwanath, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2008
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenicMax Corbett, Willy M Bogers, Jonathan L Heeney, et al.
Microbiology Spectrum|August 1, 2022
Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in NigeriaAnise N Happi, Testimony J Olumade, Olusola A Ogunsanya, et al.
Virology|October 25, 2008
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challengeWilly M J M Bogers, David Davis, Ilona Baak, et al.
The Journal of Infectious Diseases|September 20, 2014
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsionWilly M Bogers, Herman Oostermeijer, Petra Mooij, et al.
Iscience|October 20, 2023
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunityHazel Stewart, Yongxu Lu, Sarah O'Keefe, et al.
Frontiers in Immunology|August 8, 2022
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 StudyBeatriz Perdiguero, Benedikt Asbach, Carmen E Gómez, et al.
Journal of Virology|June 14, 2003
Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii)Mario L Santiago, Magdalena Lukasik, Shadrack Kamenya, et al.
Journal of Virology|February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.
Frontiers in Immunology|December 6, 2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 CasesJavier Castillo-Olivares, David A Wells, Matteo Ferrari, et al.
Frontiers in Immunology|March 13, 2023
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variantsGeorge W Carnell, Martina Billmeier, Sneha Vishwanath, et al.
Pageof 21